Objective-SAR1b plays a significant role in the assembly, organization, and function of the coat protein complex II, a critical complex for the transport of proteins from the endoplasmic reticulum to the Golgi. Recently, mutations in SARA2 have been associated with lipid absorption disorders. However, functional studies on Sar1b-mediated lipid synthesis pathways and lipoprotein packaging have not been performed. Methods and Results-Sar1b was overexpressed in Caco-2/15 cells and resulted in significantly augmented triacylglycerol, cholesteryl ester, and phospholipid esterification and secretion and markedly enhanced chylomicron production. It also stimulated monoacylglycerol acyltransferase/diacylglycerol acyltransferase activity and enhanced apolipoprotein B-48 protein synthesis, as well as elevated microsomal triglyceride transfer protein activity. Along with the enhanced chylomicrons, microsomes were characterized by abundant Sec12, the guanine exchange factor that promotes the localization of Sar1b in the endoplasmic reticulum. Furthermore, coimmunoprecipitation experiments revealed high levels of the complex components Sec23/Sec24 and p125, the Sec23-interacting protein. Finally, a pronounced interaction of Sec23/Sec24 with sterol regulatory element binding protein (SREBP) cleavage-activating protein and SREBP-1c was noted, thereby permitting the transfer of the transcription factor SREBP-1c to the nucleus for the activation of genes involved in lipid metabolism. Conclusion-Our data suggest that Sar1b expression may promote intestinal lipid transport with the involvement of the coat protein complex II network and the processing of SREBP-1c. (Arterioscler Thromb Vasc Biol. 2011;31:2692-2699.)
I ntense efforts have been made over the past 2 decades to better understand the physiological events behind chylomicron (CM) formation. [1] [2] [3] [4] CMs are essential for the transport of alimentary lipids and fat-soluble vitamins to the bloodstream via the lymphatic system. Although there has been significant progress in intestinal fat transport, major issues remain unsolved regarding the sites, steps, and identity of critical protein participants and regulation involved in lipid translocation from the enterocyte to blood circulation. Uncovering this essential information would serve to better ascertain and appropriately treat lipid transport abnormalities, including fat malabsorption and lipoprotein overproduction, which results in dyslipidemia and atherosclerosis. 5 Several groups, including ours, have contributed widely to dissecting the multistep CM assembly within the enterocyte. [1] [2] [3] [4] 6 This complex process includes cellular lipid esterification, translocation of cellular lipid pools, biogenesis and posttranslational modification of various apolipoproteins (apo), and, finally, packaging lipid and apo components into CM. Until now, it has been thought that the key process in CM assembly/secretion is the intracellular association of the essential apo B-48 with lipids 7 with the obligatory involvement of microsomal triglyceride transfer protein (MTP). 8 Mutations of apo B-48 and MTP result in hypobetalipoproteinemia and abetalipoproteinemia, respectively, with impaired lipid transfer from intestinal enterocytes into the plasma, steatorrhea, failure to thrive during infancy, and other symptoms due to deficiencies of essential fatty acids (FA) and fat-soluble vitamins. Our recent studies provided compelling evidence that Sar1b GTPase (commonly named Sar1b) also plays a pivotal role in CM exocytosis from the enterocytes because its mutations lead to CM retention disease (CRD), or Anderson disease, 9, 10 which shares common clinical characteristics with hypobetalipoproteinemia and abetalipoproteinemia. In fact, Sar1b protein rallies coat protein complex II (COPII) to form a shell around the vesicles transporting CM cargo in the secretory pathway for their budding and fusion with the Golgi.
Newly synthesized and properly folded proteins are transported from the endoplasmic reticulum (ER) to the trans-Golgi network via COPII vesicles to reach their final destination. [11] [12] [13] COPII coats are assembled from 3 components, ie, Sar1b, Sec23/24, and Sec13/31 complexes, necessary to capture cargo proteins and sculpt the ER membrane into vesicles. 14 Current models for protein sorting propose that Sar1b is first activated to function as a molecular switch for the recruitment of the 2 additional cytosolic complexes that direct vesicle budding from the ER. 15 Sar1b cycles between inactive GDP-and active GTP-bound forms play a key role in the regulation of the formation of COPII-coated vesicles. 12 COPII-coated vesicle biogenesis commences when Sar1b is converted from the GDP-to GTP-bound state, triggering a sequence of recruitment events that assemble the COPII coat and subsequently initiate the budding of COPII-coated vesicles. 16 Sar1b is likely to have a multiple functions in cargo sorting, regulation of COPII coat dynamics, and membrane deformation through the process of vesicle formation. 17, 18 Although defects in Sar1b were found to be associated with severe lipid absorption disorder in humans, this important protein has not been extensively investigated in relation to intestinal lipid transport and regulation. In particular, no studies have so far performed functional investigations to show that Sar1b may be at the center of crucial pathways of lipid transport. In the present work, functional studies were carried out to determine the regulatory influence of Sar1b on lipid synthesis, apo biogenesis, and lipoprotein formation, as well as on components that contribute to the efficiency of COPII-mediated protein export from the ER.
Methods
Experiments were performed using the Caco-2/15 cell line to overexpress Sar1B/GTPase (Sar1b ϩ/ϩ ). The intestinal cells were transduced with lentivirus-Sar1b-green fluorescent protein. After lentivirus infection, cells were allowed to proliferate until reaching confluence and differentiate for 14 days before being tested for Sar1b ϩ/ϩ and compared with control mock cells infected with empty vector. Precautions were taken to ensure that genetically modified Caco-2/15 cells were viable, fully differentiated, and endowed with normal permeability and function. Thereafter, lipid synthesis, de novo apo biogenesis, and lipoprotein assembly were assessed using radioactive precursors ([ 14 C]-oleic acid, [ 35 S]-methionine). We examined the mechanisms including the activity of various enzymes (monoacylglycerol acyltransferase, diacylglycerol acyltransferase, MTP) involved in intracellular lipid metabolism and lipoprotein assembly. The impact of Sar1b forcing on the protein expression COPII components was examined by analyzing the Sec23/24 and Sec13/31 complexes by Western blot. Moreover, a coimmunoprecipitation technique in combination with Western blotting was used to determine the interaction between COPII components and various factors (the guanine nucleotide exchange factor Sec12, the Sec23interacting protein p125A, SCAP, and sterol regulatory element binding protein-1c [SREBP-1c]), as well as between apo B-48 and L-FABP, CD36, Sar1, Sec12/Sec23/24, and p125A in pre-CM transport vesicles isolated from the ER of Sar1b ϩ/ϩ cells.
Further details are given in the supplemental materials, available online at http://atvb.ahajournals.org.
Results

Sar1b Overexpression and Cell Integrity
To examine the role played by Sar1b in intestinal lipid metabolism, studies were carried out using lentivirus as an experimental approach to generate a cellular model overexpressing Sar1b. Sar1b expression was measured following clone selection after 14-day differentiation. The infected Caco-2/15 cells exhibited a marked SAR1B gene overexpression and a significant protein increase compared with mock cells infected with green fluorescent protein lentivirus ( Figure  1 ). Because mock cells were comparable to noninfected Caco-2/15 cells in terms of gene and protein expressions (data not shown), only mock cells were used as controls in subsequent experiments.
We then examined how genetic manipulation of Sar1b level altered Caco-2/15 cell integrity. No pronounced alterations were noted in cell viability (assessed with the Trypan Blue dye exclusion method) or transepithelial resistance between mock and Caco-2/15 cells overexpressing Sar1b (data not shown). Similarly, estimation of the expression of the 2 characteristic brush border membrane markers, villin (Supplemental Figure IA) and sucrase (Supplemental Figure  IB) proteins, did not reveal significant changes. Collectively, these data suggest that genetically modified Caco-2/15 cells are viable, fully differentiated, and endowed with normal permeability and function.
Measurement of Lipid Esterification
To elucidate the impact of Sar1b ϩ/ϩ on lipid esterification and delivery, Caco-2/15 cells were cultured for 24 hours with [ 14 C]oleic acid. As illustrated in Supplemental Figure II , substantial changes were recorded in the major lipid classes in cells and media. The augmentation in Sar1b expression led to a significant augmentation in cellular triacylglycerols (TGs) ( Figure 2 ), cholestryl ester, and phospholipids (Sup- Figure 1 . Gene and protein expressions of Sar1b following Caco-2/15 cell transfection. Caco-2/15 cells were transduced with lentivirus-Sar1b-green fluorescent protein (GFP). After lentivirus infection, cells were allowed to proliferate until reaching confluence and differentiate for 14 days before being tested for Sar1b ϩ/ϩ . Control mock cells were obtained by infection with GFP lentivirus. Reverse transcription-polymerase chain reaction (A) and Western blot (B) assays were carried out, and the quantification of band intensities showed a significant increase in Sar1b gene and protein expression, respectively, in cells that were transduced with lentivirus-Sar1b-GFP compared with Caco-2/15 transduced with GFP only (mock cells). Results represent the meansϮSEM for nϭ3 independent experiments and are represented as ratio of Sar1b ϩ/ϩ to GAPDH or Sar1b ϩ/ϩ to ␤-actin. *PϽ0.001 vs control mock cells.
plemental Figure II) . A similar trend was noted in the medium lipid content on TGs (Figure 2 ), cholestryl ester, and phospholipids (Supplemental Figure II) . Together, these findings suggest a role of Sar1b ϩ/ϩ in lipid synthesis and secretion.
Apo Biosynthesis and Secretion
The subsequent step was to examine the modulation of apo production in intestinal epithelial cells overexpressing Sar1b. To this end, Caco-2/15 cells were cultured with [ 35 S]methionine for 24 hours, and the delivery of newly synthesized apos in the medium was analyzed by SDS-PAGE following immunoprecipitation. On the incubation of Caco-2/15 cells with the radiolabeled precursor, a rise in the synthesis and secretion of apo B-48 ( Figure 2 Figure IIIC) . Importantly, the ratio of apo B-48 (the main apo B form)/TGs in the medium revealed a significantly (PϽ0.001) diminished value of Sar1b ϩ/ϩ cells (2.50Ϯ0.32) compared with mock cells (4.10Ϯ0.37), suggesting an increased lipoprotein size of TG-rich lipoprotein particles.
MTP
Because the assembly of TG-rich lipoproteins represents a complex process in which apo B-48 is packaged with lipids with the obligatory involvement of MTP, we examined the activity of this key protein to gain insight into the mechanisms responsible for the induced apo B-containing lipoprotein assembly and secretion. Both the protein expression ( Figure 2 ) and the activity ( Figure 2 ) of MTP were found to be elevated in Caco-2/15 cells overexpressing Sar1b.
Lipoprotein Assembly
To determine whether Sar1b ϩ/ϩ was able to regulate lipid transport, Caco-2/15 cells were incubated with [ 14 C]oleic acid for 24 hours, medium was collected, and lipoprotein fractions were immediately separated by ultracentrifugation. Figure 3 shows that Sar1b ϩ/ϩ in Caco-2/15 cells resulted in a consistent delivery increase in the CM (2-fold, PϽ0.01) and very-low-density lipoprotein (1.8-fold, PϽ0.01) fractions.
Monoacylglycerol Acyltransferase and Diacylglycerol Acyltransferase Activity Assay
The rise in intracellular production of TGs prompted us to determine whether the activity of monoacylglycerol acyltransferase and diacylglycerol acyltransferase, involved in FA esterification, was influenced by Sar1b forcing. Caco-2/15 cells with Sar1b ϩ/ϩ displayed a significant increase in the activity levels of monoacylglycerol acyltransferase (Supplemental Figure IVA 
Process Specificity
To test whether all the lipid and lipoprotein processes observed in response to Sar1b overexpression were specific, we have evaluated the impact of Sar1b ϩ/ϩ on cellular incorporation of various nutrients. No significant changes were observed between mock and genetically modified cells in the uptake of calcium (2.22Ϯ0.17 versus 2.34Ϯ0.20 pmol/mg protein per minute), glutamine (209.45Ϯ17.22 versus 188.33Ϯ21.23 pmol/mg protein per minute), and deoxyglucose (563.3Ϯ37.3 versus 548.1Ϯ42.5 pmol/mg protein per minute), respectively. Therefore, one cannot argue that the overexpression of this gene globally generates higher cell functions.
Does Sar1b Overexpression Have an Impact on Sar1a Protein Mass?
In mammals, there are 2 isoforms of Sar1, Sar1a and Sar1b. The second human protein isoform of Sar1, Sar1a, is encoded by the SAR1A gene (OMIM 607691). To determine whether Sar1b forcing influences the expression of Sar1a, we assessed the mass protein of the latter. Western blot analysis could not reveal any changes in Sar1a protein expression in response to Sar1b overexpression in Caco-2/15 cells (Supplemental Figure V) . These findings clearly exclude the interference of Sar1a with the TG-rich lipoprotein assembly mediated by Sar1b ϩ/ϩ .
Sar1b Forcing and Involvement of COPII Components
As mentioned before, the COPII coat consists of the small GTPase Sar1b, the Sec23/24, and the Sec13/31 complexes that sequentially bind to the ER membrane. We were first interested to determine whether Sar1b overexpression alters the expression of Sec12 because this ER-localized transmembrane protein catalyzes GDP/GTP exchange on Sar1b, resulting in GTP loaded Sar1b that recruits the cargo adaptor complex Sec23/Sec24 to ER exit domains. 19 Using Western blot, a substantial increase was noted in the protein mass of Sec12 in the microsomal fraction prepared following cellular Sar1b forcing ( Figure 4A ). We thereafter turned to Sec23, which represents the GTPase-activating protein that stimulates the enzymatic activity of Sar1b. 20 Once again, analysis by Western blotting revealed an abundant quantity not only of Sec23 ( Figure 4C ) but also of Sec24 ( Figure 4D ) in microsomal fractions, but without any significant changes in Sec13 ( Figure 4B ) and Sec31 ( Figure 4E ) protein expression. We finally focused on p125A protein, which is required for Sec23 interaction, 21 and detected a raised protein level in the microsomal fraction of cells with Sar1b overexpression ( Figure 4F) .
To determine the impact of Sar1b overexpression on the interaction of various components that trigger the COPII machinery, we used the coimmunoprecipitation technique. This experimental approach allowed us to show a more intense cooperation between the Sec12 guanine nucleotide exchange factor, the Sec23/Sec24 adaptor complex, and the Sec23-interacting p125A protein ( Figure 5 ).
Because SREBP-1c is considered to be profoundly involved in the transcriptional regulation of lipogenic enzymes following its lateral movement in COPII-coated vesicles, we assessed its interaction with COPII proteins. Coimmunoprecipitation studies in microsomes isolated from Caco-2/15 cells with Sar1b overexpression documented a strong coupling of Sec23/Sec24 with SCAP/SREBP1-c complex (Figure 6A to 6C ). Furthermore, more SREBP1-c signal intensity was noted in the nucleus fraction ( Figure 6D ).
Finally, for validation purposes, we isolated the pre-CM transport vesicles from the ER of Sar1b ϩ/ϩ cells, as reported previously. [22] [23] [24] [25] [26] The characterization of these vesicles revealed various proteins that collocate with apo B-48, including liver-FA binding proteins and CD36, as well as Sar1, Sec12/Sec23/24, and p125A (Supplemental Table I ).
Discussion
Intensive work on genetic disorders of fat transport has afforded new insights into the mechanisms involved in intestinal lipid handling and lipoprotein metabolism. Three inherited disorders, namely abetalipoproteinemia, hypobetalipoproteinemia, and CRD, have provided significant advances in our understanding of human physiology related to the assembly of TG-rich lipoproteins. Although their molecular genetic causes have been defined and it is particularly stressed that MTP, apo B, and Sar1b are essential and key components of the TG-rich lipoprotein assembly pathway, relatively few functional studies at the molecular and cellular level have been reported specifically on CRD. To tackle this issue in the present work, we have successfully overexpressed Sar1b in Caco-2/15 cells and can for the first time document that the stable forcing of Sar1b is tightly associated with the amplification of lipid transport. Mechanistically, we were able to highlight the Sar1b-mediated induction of apo B and MTP to augment the assembly of TG-rich lipoproteins. Our findings also emphasize the requirement of particular proteins, such as Sec12, p125A, and Sec23/Sec24, to accommodate Sar1b overexpression for the stimulation of lipid transport via lipoprotein assembly and secretion. Finally, the lateral movement of SREBP-1c into COPII-coated vesicles on ER membranes seems to be implicated in the regulation of lipid processing.
The secretion process of lipoproteins has been largely described in Caco-2 cells under different physiological conditions. Studies from various laboratories have reported the low capacity of Caco-2 cells to transport lipids under the form of lipoproteins. About 15% to 20% of TGs are exported, whereas residual TGs are retained, as was the case in the present investigation. On the other hand, Figure 2 documents the total FA incorporation and esterification, which indicates higher FA uptake in Sar1b ϩ/ϩ cells than in control mock cells.
The formation of CMs, the largest lipoproteins synthesized exclusively by intestinal epithelial cells, is crucial for the transport of alimentary lipids and fat-soluble vitamins. To date, mechanisms by which lipids are recruited during CM assembly are incompletely understood. According to the prevailing concept, association of apo B-48 with lipids is mediated by MTP in the rough ER, resulting in a lipid-poor, small apo B-48-containing particle that serves as a precursor of mature CM. Our laboratory has not only contributed to illustrating the essential role of apo B-48 and MTP but also been able to point out the absolute requirement of Sar1b for CM assembly. 9, 10, 27 Mutations of the SARA2 gene coding for Sar1b lead to CRD, characterized by varying degrees of chronic fat malabsorption, hypocholesterolemia, fat-soluble vitamin deficiency, failure to thrive, chronic diarrhea, and neurological manifestations. 6,10,27-30 Importantly, the intracel- To determine the direct interactions of Sar1b with important proteins required for coat protein complex II formation, the coimmunoprecipitation technique was used. Microsomal proteins (50 g) were reacted with Sar1b antibodies. The immunoprecipitates were subjected to gel electrophoresis and transferred to nitrocellulose membranes. Thereafter, the latter were blotted with antibodies directed against Sec12, Sec13, Sec23, Sec24, and p125A. Figure 6 . Coimmunoprecipitation of Sec23, Sec24, SCAP, and sterol regulatory element binding protein-1c (SREBP-1c) in Caco-2/15 cells. To determine the direct interactions of Sar1b with important proteins required for coat protein complex II formation, the coimmunoprecipitation technique was used. Microsomal proteins (50 g) were reacted with Sar1b antibodies. The immunoprecipitates were subjected to gel electrophoresis and transferred to nitrocellulose membranes. Thereafter, the latter were blotted with antibodies directed against Sec23, Sec24, SCAP, and SREBP-1c. lular traffic of apo B-48-containing CM is dependent on the COPII coat complex, which buds vesicles from the ER membrane to transport newly synthesized proteins to the Golgi apparatus. Because COPII vesicle biogenesis and assembly begins when Sar1b triggers a sequence of recruitment events that assemble the COPII coat from its cytosolic components and ultimately drives vesicle budding, 12 we have reasoned that Sar1b ϩ/ϩ may influence intestinal lipoprotein trafficking and sorting. Indeed, the present experiments reveal a stimulation of CM assembly and output in the presence of abundant Sar1b in Caco-2/15 cell line. Therefore, it seems that by being critical for COPII functioning, Sar1b GTPase action represents a limiting step that is determinant for the routing/movement of apo B-48-containing CM from the ER to the Golgi apparatus. Sar1b likely activates cargo sorting and completion of the final fission plays to fuel apo B-48containing CM trafficking.
Apo B-48 is the principal protein component of CM and is cotranslationally lipidated by MTP. 31 The lipidation process may be facilitated by the addition of TGs, and when this occurs, the production of apo B-48 and CM increases. Accordingly, it was shown that enhanced apo B output likely reflects adequate lipidation of apo B by MTP, a critical player in the early posttranslational regulation of apo B. 32 One can therefore assume that profuse Sar1b efficiently drives COPII machinery action capable of diverting apo B-48 to the secretory pathway and promoting CM processing and secretion. Additional studies are needed to delineate the mechanisms of action of Sar1b, because the information on the processes of translational apo B-48 in the intestine is not as abundant as the apo B-100 in the liver, which is retrotranslocated to the cytoplasm through the translocon in lipid-poor situations, ubiquitylated, and degraded by the proteasome. 33 Nevertheless, the available literature allows us to mention that apo B-48 may be regulated by the ubiquitin-proteasome pathway and cytosolic hsp70. Our previous observations suggest that the development of insulin resistance and diabetes stimulated the intestinal transport of lipids by augmenting apo B-48 synthesis through reduced proteasomal degradation activity, resulting in enhanced TG-rich lipoprotein assembly and secretion. 5 Moreover, Fischer's group showed that hsp90 facilitates the interaction between ER-associated apo B and components of the proteasomal pathway, perhaps in cooperation with hsp70. 34 In the present work, the presence of the proteasome inhibitor benzyloxycarbonyl-Leu-Leu-leucinal (MG132) at the concentration of 50 mol/L was ineffective in augmenting the levels of apo B-48 (data not shown), suggesting a direct effect of increased biogenesis rather than any involvement in proteasomal degradation activity in response to Sar1b overexpression. ER export is mediated by vesicle formation at specialized ER domains known as the ER exit sites by the COPII complex. COPII subunits must first be recruited to the correct sites on the ER membrane, ie, that of the ER exit sites. The COPII coat is formed through sequential binding of 3 cytosolic components, a small GTPase Sar1, 15, 19, 21 the Sec23/ Sec24 heterodimer complex, 35 and the Sec13/Sec31 heterotetramer complex, 36 to the ER exit sites. Following Sar1-GTP binding to the Sec23/24p complex via Sec23p, Sec24p captures the cytoplasmically exposed signal of the transmembrane cargo 37, 38 to form a prebudding complex. 39 Sec23p is the GTPase-activating protein for Sar1 and therefore stimulates GTP hydrolysis on binding to Sar1, 20 leading to disassembly of the prebudding complex. 40 Our own findings reinforce the need for increased amounts of Sec23/Sec24 in parallel with the appeal of profuse Sar1b to cope with the transfer of proteins and lipoproteins from ER to Golgi.
Although 2 isoforms characterize Sar1, only Sar1b has been associated with the rare recessive disorder CRD, 9 characterized by the selective retention of CM-like particles within the ER of enterocytes. 30, 41 To date, 11 separate mutations in the SAR1b gene (SARA2) have been detected. 42 In some patients' duodenal biopsies, the fall in Sar1b gene expression was related to Sar1 mRNA elevation, an indication of a certain degree of compensation. 43 However, in the present investigation, we could not detect any changes in Sar1a protein expression in response to Sar1b overexpression in Caco-2/15 cells.
The sequence of COPII protein assembly was established by the sequential addition of COPII components to an in vitro ER vesicle budding assay. 44, 45 Even though COPII vesicle formation could be minimally reconstituted using purified COPII proteins, 14 additional regulatory factors, such as Sec12 and p125A, are obviously necessary to efficiently support ER-Golgi transport. Indeed, assembly of the COPII coat is initiated through the activation of Sar1 through conversion of its GDP to GTP under the control of Sec12, a guanine-nucleotide-exchange factor for Sar1. 46 This GDP-to-GTP transition triggers the exposure of the N-terminal amphipathic ␣-helix element of Sar1 that inserts into the ER membrane. 47, 48 On the other hand, p125A was identified as an interacting partner for Sec23A to facilitate ER export from the ER exit sites. 49, 50 p125 contains an N-terminal prolinerich region responsible for the interaction with Sec23p. 51 Our results here show that p125A is a Sec23A-interacting protein and likely part of a Sec23/Sec24/p125A heterohexameric complex, for which additional studies are required to define its actual contribution to the efficiency of COPII-mediated protein and especially lipoprotein export from the ER.
SREBPs are transcription factors that belong to the basic helix-loop-helix leucine zipper family and are considered to be profoundly involved in the transcriptional regulation of cholesterogenic and lipogenic enzymes. 52, 53 Unlike other members of the basic helix-loop-helix leucine zipper family, SREBPs are synthesized as precursors bound to the ER. To activate lipid synthesis, the SREBPs must be transported to the Golgi, where proteases release the active domains that enter the nucleus. ER-to-Golgi transport requires that the SREBPs form complexes with SCAP, an escort protein. 54 On inhibition, SCAP is tightly associated with Insig-1, causing retention of the SCAP/SREBP-1c complex in the ER and thus preventing proteolytic processing of the nascent SREBP-1c. Conversely, on activation, Insig-1 dissociates from the SCAP/SREBP-1c complex, thereby facilitating its transport to the Golgi, where full-length SREBP-1c undergoes proteolysis to generate nSREBP-1c. It has been reported that the SCAP/SREBP complex clusters laterally with other proteins into COPII-coated vesicles that bud from the ER. 55 Our studies showed that clustering of the SCAP/SREBP-1c complex is augmented with the overexpression of Sar1b that recruits the heterodimeric protein Sec23/24. Accelerated movement of SREBP-1c would permit connection with genes in the nucleus with the induction of lipid and lipoprotein processing.
Previous studies reported that pre-CM transport vesicles are large COPII-containing vesicles that transport the developing CM from the ER to the Golgi. 24, 25 Once detached from the ER membrane, the pre-CM transport vesicles dock and then fuse with the Golgi. In fact, the exit step of the pre-CM from the ER is the rate-limiting step in which dietary TG traverses the intestinal absorptive cell. 56, 57 According to our data, it is reasonable to assume that the presence in abundance of Sar1b, the initiator of the COPII complex, facilitates the formation of the vesicles, their fusion with the Golgi, and lipoprotein trafficking.
